ECSP034616A - Nuevos derivados de pirazolopiridina sustituidos con piridina - Google Patents

Nuevos derivados de pirazolopiridina sustituidos con piridina

Info

Publication number
ECSP034616A
ECSP034616A EC2003004616A ECSP034616A ECSP034616A EC SP034616 A ECSP034616 A EC SP034616A EC 2003004616 A EC2003004616 A EC 2003004616A EC SP034616 A ECSP034616 A EC SP034616A EC SP034616 A ECSP034616 A EC SP034616A
Authority
EC
Ecuador
Prior art keywords
pirazolopiridina
piridine
substituted
new derivatives
designates
Prior art date
Application number
EC2003004616A
Other languages
English (en)
Inventor
Johannes Peter Stasch
Stefan Weigand
Elisabeth Perzborn
Elke Stahl
Alexander Straub
Dieter Lang
Klaus Dembowsky
Achim Feurer
Alija Cristina Alonso
Dietmar Flubacher
Frank Wunder
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ECSP034616A publication Critical patent/ECSP034616A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

En la que R1 designa 4-piridina o 3 piridinilo R2 designa H. NH2 o halógeno, así como sales isomeros e hidratos de los mismos como estimulantes de la guanilatociclasa soluble y para el uso como agentes para el tratamiento de enfermedades cardiocirculatorias, hipertonia, trastornos tromboembolicos e isquemias disfunción sexual o inflamaciones así como para el tratamiento de enfermedades del sistema nervioso central.
EC2003004616A 2000-11-22 2003-05-21 Nuevos derivados de pirazolopiridina sustituidos con piridina ECSP034616A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10057753 2000-11-22

Publications (1)

Publication Number Publication Date
ECSP034616A true ECSP034616A (es) 2003-06-25

Family

ID=7664122

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004616A ECSP034616A (es) 2000-11-22 2003-05-21 Nuevos derivados de pirazolopiridina sustituidos con piridina

Country Status (12)

Country Link
KR (1) KR20030065519A (es)
DE (2) DE10131987A1 (es)
DO (1) DOP2001000291A (es)
EC (1) ECSP034616A (es)
GT (1) GT200100235A (es)
HN (1) HN2001000261A (es)
MY (1) MY127212A (es)
PE (1) PE20020581A1 (es)
RU (1) RU2003118584A (es)
SV (1) SV2003000743A (es)
UA (1) UA74404C2 (es)
ZA (1) ZA200303887B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102485724B (zh) * 2010-12-06 2015-08-12 中国人民解放军军事医学科学院毒物药物研究所 取代噻吩基吡唑并吡啶类化合物及其医药用途
HUE053745T2 (hu) 2011-11-25 2021-07-28 Adverio Pharma Gmbh Helyettesített 5-fluor-1H-pirazolopiridin kristályos formában
ES2985316T3 (es) * 2016-10-11 2024-11-05 Bayer Pharma AG Combinación que contiene el estimulador sGC vericuguat y el antagonista de los receptores de corticoides minerales finerenona

Also Published As

Publication number Publication date
GT200100235A (es) 2002-06-25
DE10131987A1 (de) 2002-05-23
MY127212A (en) 2006-11-30
ZA200303887B (en) 2004-06-21
SV2003000743A (es) 2003-01-13
DE50106655D1 (de) 2005-08-04
KR20030065519A (ko) 2003-08-06
RU2003118584A (ru) 2004-12-20
PE20020581A1 (es) 2002-07-13
DOP2001000291A (es) 2002-12-15
UA74404C2 (uk) 2005-12-15
HN2001000261A (es) 2002-01-30

Similar Documents

Publication Publication Date Title
AR031176A1 (es) Nuevos derivados de pirazolpiridina sustituidos con piridina
ECSP045081A (es) Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
SV2002000022A (es) Inhibidores de recanalizacion de la monoamida para el tratamiento de los desordenes del sistema nervioso central ref. pc10434
PA8442201A1 (es) Derivados de 6-fenilpiridil-2-amina
GT199900150A (es) 1,2,3,4-tetrahidroquinolinas 2-sustituidas 4-carboxiamino sustituidas.
ES2132223T3 (es) Derivados de indol condensados en calidad de antagonistas del receptor 5-ht4.
MXPA04004370A (es) Derivados policiclicos de guanina inhibidores de fosfodiesterasa v.
UY28150A1 (es) Agentes terapeuticos
BR9911575A (pt) Heterocìclicos de alquilsulfóxido 4-benzil piperidina e seu uso como antagonistas receptores de nmda seletivas do subtipo
CR7042A (es) Indanil aminas aciladas y su uso como farmacos
DK1578740T3 (da) 1,2,4-triaminobenzenderivater, der er egnede til behandling af lidelser i centralnervesystemet
UY27055A1 (es) Activadores heteroaromaticos fusionados de la glucoquinasa
CL2004000655A1 (es) Compuestos derivados de piperidin-2-ona 1,6-disustituidos, sus sales, composicion farmaceutica, agonistas del receptor ep4; uso de los compuestos para tratar hipertension ocular, glaucoma.
ES2156287T3 (es) Derivados de difenilmetilen piperidina.
MX9700429A (es) El uso de compuestos de tiazol y tiadiazol.
ECSP045473A (es) Derivados de 1-(aminoalquil)-3-sulfonilindol y 1-aminoalquil-3-sulfonilindazol como ligandos de 5-hidroxitriptamina-6
AR028705A1 (es) Bis-arilsulfonas
DE60020595D1 (de) 3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p38-kinase-inhibitoren
PA8527401A1 (es) 7-oxo-piridopirimidinas (ii)
IT1282673B1 (it) Derivati della camptotecina e loro uso come agenti antitumorali
ATE302776T1 (de) Kondensierte pyridoindolderivate
UY27998A1 (es) Piperazinas sustituidas sustituidas heterocíclicas para el tratamiento de la esquizofrenia
ATE281439T1 (de) 3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p38-kinase-inhibitoren
AR029588A1 (es) Nueva forma (r)-n-[5-metil-8-(4-metilpiperazina-1-il)-1,2,3,4-tetrahidro-2-naftil]-4-morfolinobenzamida
ES2196069T3 (es) Derivados morfinoides condensados con heterociclos.